Many people know thyroid cancer as a cancer type with a relatively good prognosis, but the disease still has profound effects on patients and survivors, writes thyroid cancer survivor Carly Flumer.
by Carly Flumer
POLICY MATTERS
Advocating for federal funds for medical research pays off when the effort is constant and compelling.
by Brandon L. Leonard, MA, and J. Tod Guidry, PhD
Get Involved
Various kinds of artistic expression can play a role in processing the emotional effects of cancer.
by Bradley Jones
Patients find each other online and get support they say is unparalleled, but with openness comes concern about privacy.
by Kate Yandell
Survivor Profile
Brain cancer survivor Lanette Veres sends cards and packages to others with the disease. She believes no one should face cancer alone.
by Lindsey Konkel
FORWARD LOOK
New law mandates that cancer drugs get tested in kids in clinical trials.
by Sharon Tregaskis
High cost may still limit access.
by Nancy Averett
Patient advocates have become a vital part of the San Antonio Breast Cancer Symposium. Opportunities for advocates continue to multiply.
by Marci A. Landsmann
The financial burden of a cancer diagnosis can lower a patient’s credit score.
by Shelly Rosenfeld
A coalition of wives of African leaders, originally dedicated to addressing HIV/AIDS, is now also taking on the growing problem of cancer.
by Bradley D. Miller, PhD
Melvin Mann benefited from joining a pivotal clinical trial for chronic myelogenous leukemia, but participation came with logistical challenges.
by Melvin Mann
After discovering that some patients weren’t able to access the food they needed, a community oncology practice partnered with a local food bank.
by Jen Tota McGivney
The winter 2019/2020 issue of Cancer Today tells the stories of people working to improve privacy protections for patients seeking support online, expand access to genetic testing and boost the efficacy of immunotherapy to benefit more patients.
by Kevin McLaughlin
As a new decade begins to unfold, what advancements can we expect in the field of oncology?
The U.S. Food and Drug Administration expanded the use of a targeted therapeutic to include treating certain patients with pancreatic cancer.
Research continued to drive progress across the spectrum of cancer care in the form of new ways to prevent, detect, diagnose, and treat the disease.
Follow My Lead
donate to the AACR